Best-case series for the use of immuno-augmentation therapy and naltrexone for the treatment of cancer.

P. Shekelle; I. Coulter; M. L. Hardy; S. C. Morton; J. T. Favreau; J. Gagne; S. A. Coulter; J. Udani; E. A. Roth; L. K. Jungvig; S. Newberry; L. Rohr; L. R. Ramirez

Best-case series for the use of immuno-augmentation therapy and naltrexone for the treatment of cancer.

P. Shekelle, I. Coulter, M. L. Hardy, S. C. Morton, J. T. Favreau, J. Gagne, S. A. Coulter, J. Udani, E. A. Roth, L. K. Jungvig, S. Newberry, L. Rohr, L. R. Ramirez

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Original language	English (US)
Journal	Evidence report/technology assessment (Summary)
Issue number	78
State	Published - Apr 2003
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

Cite this

@article{53f6b22bd6c74c24844ad9a612c0d610,

title = "Best-case series for the use of immuno-augmentation therapy and naltrexone for the treatment of cancer.",

author = "P. Shekelle and I. Coulter and Hardy, {M. L.} and Morton, {S. C.} and Favreau, {J. T.} and J. Gagne and Coulter, {S. A.} and J. Udani and Roth, {E. A.} and Jungvig, {L. K.} and S. Newberry and L. Rohr and Ramirez, {L. R.}",

year = "2003",

month = apr,

language = "English (US)",

journal = "Evidence report/technology assessment (Summary)",

issn = "1530-440X",

publisher = "Public Health Services, US Dept of Health and Human Services",

number = "78",

}

TY - JOUR

T1 - Best-case series for the use of immuno-augmentation therapy and naltrexone for the treatment of cancer.

AU - Shekelle, P.

AU - Coulter, I.

AU - Hardy, M. L.

AU - Morton, S. C.

AU - Favreau, J. T.

AU - Gagne, J.

AU - Coulter, S. A.

AU - Udani, J.

AU - Roth, E. A.

AU - Jungvig, L. K.

AU - Newberry, S.

AU - Rohr, L.

AU - Ramirez, L. R.

PY - 2003/4

Y1 - 2003/4

UR - http://www.scopus.com/inward/record.url?scp=84921701817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921701817&partnerID=8YFLogxK

M3 - Article

C2 - 12751155

AN - SCOPUS:84921701817

JO - Evidence report/technology assessment (Summary)

JF - Evidence report/technology assessment (Summary)

SN - 1530-440X

IS - 78

ER -

Best-case series for the use of immuno-augmentation therapy and naltrexone for the treatment of cancer.

ASJC Scopus subject areas

Other files and links

Cite this